Results 261 to 270 of about 47,941 (305)
Some of the next articles are maybe not open access.

Mifepristone and misoprostol

Current Obstetrics & Gynaecology, 1999
In recent years. mifepristone and misoprostol have generated a lot of interest. Both have been extensively investigated for their applications in abortion, but they can be used for other indications (Table 1). To view them as merely abortifiacients is to undermine their potential in these other applications.
Ho, PC, Ngai, SW
openaire   +4 more sources

Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease.

Equine Veterinary Journal, 2019
BACKGROUND Previous studies have demonstrated a poor response to healing of gastric glandular lesions with oral omeprazole and other medications. OBJECTIVES To evaluate the efficacy of two novel treatments (misoprostol [M] and combined omeprazole ...
G. Varley   +4 more
semanticscholar   +1 more source

Misoprostol and congenital anomalies

Pharmacoepidemiology and Drug Safety, 2000
Purpose- To evaluate the risk of having a baby with congenital anomalies in mothers who used misoprostol during pregnancy.Methods- Hospital-based case - control study from Hospital Chateaubriand, Fortaleza, Brasil. Cases were 37 babies weighing less than 1500 g with congenital anomalies of various types, and the comparison group included 387 infants ...
Barbara D'Avanzo   +4 more
openaire   +4 more sources

Misoprostol in Labor Induction

Journal of Obstetrics and Gynaecology Research, 2001
AbstractThe efficacy of a new dosing regimen of misoprostol, a recently introduced labor‐inducing agent, was studied.Fifty‐eight patients received 50 μg of misoprostol intravaginally and the dose was repeated every 3 hours until uterine contractions begin.
Tufekci, M   +5 more
openaire   +4 more sources

Cytotec (Misoprostol)

Gastroenterology Nursing, 1990
NSAIDs have been associated with gastric ulcers and life-threatening complications, including hemorrhage and perforation. Cytotec (misoprostol) is the only drug approved for the prevention of NSAID-induced gastric ulcers. The administration of Cytotec represents benefits, particularly to an elderly population in which the usage trend of NSAIDs is ...
openaire   +2 more sources

Misoprostol Therapeutics Revisited

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
Misoprostol, a prostaglandin E1analog, is a racemate of four stereoisomers. On administration it rapidly de‐esterifies to its active form, misoprostolic acid. Misoprostolic acid is 85% albumin bound and has a half‐life of approximately 30 minutes. It is excreted in urine as inactive metabolites.
Fakhreddin Jamali   +2 more
openaire   +3 more sources

Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion

American Journal of Obstetrics and Gynecology, 2003
The purpose of this study was to evaluate the efficacy, side-effect profile, and follow-up rates in women who obtain a medical abortion in a nonresearch setting.From December 1, 2000, to June 30, 2001, we prospectively followed 218 women who had been evaluated in our private office for medical abortion.
Maria Holovanisin   +6 more
openaire   +3 more sources

Acute misoprostol toxicity

Annals of Emergency Medicine, 1991
Misoprostol (Cytotec) is a recently released prostaglandin E1 analog approved for use in prevention of nonsteroidal anti-inflammatory drug-induced gastropathy. We report one of the first known examples of toxicity in an acute ingestion since the drug was first released in international markets in 1984. After an accidental ingestion of 3 mg misoprostol (
Kathryn H Meier, David J Graber
openaire   +3 more sources

Misoprostol for induction of labor

Seminars in Perinatology, 2015
Labor-induction rates have increased considerably in the United States as well as around the world. With up to half of all induced labors requiring cervical ripening, prostaglandins have been utilized to increase induction success and achieve vaginal delivery.
Megan L. Stephenson, Deborah A. Wing
openaire   +3 more sources

Labor induction with misoprostol

American Journal of Obstetrics and Gynecology, 1999
Misoprostol, a prostaglandin E(1 ) analog, is widely used in the United States for cervical ripening and labor induction. Its use for these indications is not approved by the US Food and Drug Administration. The only Food and Drug Administration-approved indication in the product labeling is the treatment and prevention of intestinal ulcer disease ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy